MUMBAI, India, Aug. 12 -- Intellectual Property India has published a patent application (202637035320 A) filed by Shanghai Qilu Pharmaceutical Research And Development Centre Ltd. on March 24, 2026, for Auristatin Derivative And Antibody-Drug Conjugate Thereof.
Inventors include Wang, Junfei; Huang, Ying; Bi, Xiaoyang; Cui, Changyi; Qin, Wenwu; Han, Fengying; Li, Mengjia; Huang, Wenshu; Ma, Cuicui; Ma, Lina; Zhang, Meijuan; Chen, Dong; Wang, Xinmei; Ai, Xianwei; Yang, Yang; Sun, Daqing; and Tao, Weikang.
The application for the patent was published on August 07, 2026, under issue no. 32/2026.
Abstract: The present invention relates to a cytotoxic compound and an antibody-drug conjugate thereof, and relates in particular to an auristatin derivative, a preparation method for an antibody-drug conjugate thereof, and a use.
Disclaimer: Curated by HT Syndication.
